Senior insider sale
ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$41.4K
10.67K shares
What this filing means
MALIK FADY IBRAHAM plans to sell 10.67K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $41.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001959173-26-005144
Director
Since Mar 2022
10.67K
Shares to sell
$41.4K
Approx. market value
10.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/18/2026
10.67KTotal acquired10.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/18/2026 | Restricted Stock Vesting Compensation | 10.67K | — |
| Total | 10.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.67K
Market value
$41.4K
7/7/2026
Total
Units
10.67K
Value
$41.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/7/2026 | 10.67K | $41.4K | NASDAQ | Planned |
| Total | 10.67K | $41.4K | ||